CDX1 is an important molecular mediator of Barrett's metaplasia.
The molecular pathogenesis of Barrett's metaplasia (BM) of the esophagus is poorly understood. The change to an intestinal phenotype occurs on a background of esophagitis due to refluxing acid and bile. CDX1, an important regulator of normal intestinal development, was studied as a potential ke...
Main Authors: | Wong, N, Wilding, J, Bartlett, S, Liu, Y, Warren, B, Piris, J, Maynard, N, Marshall, R, Bodmer, W |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2005
|
Similar Items
-
EpCAM and gpA33 are markers of Barrett's metaplasia.
by: Wong, N, et al.
Published: (2006) -
Immunohistochemical Expression of CDX2 in Gastroesophageal Junction Biopsies: An Emerging Marker for Early Intestinal Differentiation of Barrett’s Metaplasia
by: Twisha Adhikari, et al.
Published: (2022-04-01) -
Residual embryonic cells as precursors of a Barrett's-like metaplasia.
by: Wang, X, et al.
Published: (2011) -
Intestinal Metaplasia in Barrett’s Oesophagus: A Clinicopathological Study
by: Jaya Bagchi Samaddar, et al.
Published: (2023-03-01) -
Prevention of Barrett's metaplasia in a human model of duodenogastro-oesophageal reflux
by: Richard J. Cade, et al.
Published: (2013-09-01)